nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolcapone—CYP2C9—cardial valve—systemic scleroderma	0.0665	0.676	CbGeAlD
Tolcapone—COMT—smooth muscle tissue—systemic scleroderma	0.00693	0.0705	CbGeAlD
Tolcapone—COMT—skin of body—systemic scleroderma	0.00684	0.0695	CbGeAlD
Tolcapone—COMT—digestive system—systemic scleroderma	0.00547	0.0556	CbGeAlD
Tolcapone—COMT—tendon—systemic scleroderma	0.00521	0.0529	CbGeAlD
Tolcapone—COMT—lung—systemic scleroderma	0.00457	0.0465	CbGeAlD
Tolcapone—CYP2C9—digestive system—systemic scleroderma	0.00288	0.0292	CbGeAlD
Tolcapone—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000458	0.000508	CcSEcCtD
Tolcapone—Diarrhoea—Captopril—systemic scleroderma	0.000457	0.000507	CcSEcCtD
Tolcapone—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000457	0.000507	CcSEcCtD
Tolcapone—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000457	0.000506	CcSEcCtD
Tolcapone—Irritability—Methotrexate—systemic scleroderma	0.000456	0.000506	CcSEcCtD
Tolcapone—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000456	0.000506	CcSEcCtD
Tolcapone—Erectile dysfunction—Prednisone—systemic scleroderma	0.000455	0.000505	CcSEcCtD
Tolcapone—Feeling abnormal—Leflunomide—systemic scleroderma	0.000454	0.000504	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000454	0.000503	CcSEcCtD
Tolcapone—Fatigue—Mycophenolic acid—systemic scleroderma	0.000453	0.000503	CcSEcCtD
Tolcapone—Mood swings—Methotrexate—systemic scleroderma	0.000453	0.000502	CcSEcCtD
Tolcapone—Nausea—Mometasone—systemic scleroderma	0.000452	0.000501	CcSEcCtD
Tolcapone—Anorexia—Lisinopril—systemic scleroderma	0.000451	0.000501	CcSEcCtD
Tolcapone—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000451	0.0005	CcSEcCtD
Tolcapone—Constipation—Mycophenolic acid—systemic scleroderma	0.000449	0.000499	CcSEcCtD
Tolcapone—Pain—Mycophenolic acid—systemic scleroderma	0.000449	0.000499	CcSEcCtD
Tolcapone—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000449	0.000498	CcSEcCtD
Tolcapone—Weight decreased—Prednisone—systemic scleroderma	0.000447	0.000496	CcSEcCtD
Tolcapone—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000447	0.000495	CcSEcCtD
Tolcapone—Cough—Mycophenolate mofetil—systemic scleroderma	0.000443	0.000492	CcSEcCtD
Tolcapone—Hypotension—Lisinopril—systemic scleroderma	0.000442	0.000491	CcSEcCtD
Tolcapone—Dizziness—Captopril—systemic scleroderma	0.000442	0.00049	CcSEcCtD
Tolcapone—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000439	0.000487	CcSEcCtD
Tolcapone—Urticaria—Leflunomide—systemic scleroderma	0.000438	0.000485	CcSEcCtD
Tolcapone—Body temperature increased—Leflunomide—systemic scleroderma	0.000436	0.000483	CcSEcCtD
Tolcapone—Abdominal pain—Leflunomide—systemic scleroderma	0.000436	0.000483	CcSEcCtD
Tolcapone—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000435	0.000482	CcSEcCtD
Tolcapone—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000433	0.00048	CcSEcCtD
Tolcapone—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000433	0.00048	CcSEcCtD
Tolcapone—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000433	0.00048	CcSEcCtD
Tolcapone—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000433	0.00048	CcSEcCtD
Tolcapone—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000432	0.000479	CcSEcCtD
Tolcapone—Myocardial infarction—Prednisone—systemic scleroderma	0.000432	0.000479	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000431	0.000478	CcSEcCtD
Tolcapone—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000431	0.000478	CcSEcCtD
Tolcapone—Hypersensitivity—Azathioprine—systemic scleroderma	0.00043	0.000477	CcSEcCtD
Tolcapone—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00043	0.000477	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00043	0.000477	CcSEcCtD
Tolcapone—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000428	0.000474	CcSEcCtD
Tolcapone—Paraesthesia—Lisinopril—systemic scleroderma	0.000425	0.000471	CcSEcCtD
Tolcapone—Vomiting—Captopril—systemic scleroderma	0.000425	0.000471	CcSEcCtD
Tolcapone—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000423	0.000469	CcSEcCtD
Tolcapone—Dyspnoea—Lisinopril—systemic scleroderma	0.000422	0.000468	CcSEcCtD
Tolcapone—Rash—Captopril—systemic scleroderma	0.000421	0.000467	CcSEcCtD
Tolcapone—Dermatitis—Captopril—systemic scleroderma	0.000421	0.000467	CcSEcCtD
Tolcapone—Somnolence—Lisinopril—systemic scleroderma	0.000421	0.000467	CcSEcCtD
Tolcapone—Headache—Captopril—systemic scleroderma	0.000419	0.000464	CcSEcCtD
Tolcapone—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000418	0.000464	CcSEcCtD
Tolcapone—Dyspepsia—Lisinopril—systemic scleroderma	0.000417	0.000462	CcSEcCtD
Tolcapone—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000415	0.000461	CcSEcCtD
Tolcapone—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000415	0.000461	CcSEcCtD
Tolcapone—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000415	0.00046	CcSEcCtD
Tolcapone—Asthma—Methotrexate—systemic scleroderma	0.000413	0.000458	CcSEcCtD
Tolcapone—Infection—Mycophenolate mofetil—systemic scleroderma	0.000412	0.000457	CcSEcCtD
Tolcapone—Decreased appetite—Lisinopril—systemic scleroderma	0.000412	0.000456	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000409	0.000453	CcSEcCtD
Tolcapone—Fatigue—Lisinopril—systemic scleroderma	0.000408	0.000453	CcSEcCtD
Tolcapone—Shock—Mycophenolate mofetil—systemic scleroderma	0.000408	0.000453	CcSEcCtD
Tolcapone—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000407	0.000451	CcSEcCtD
Tolcapone—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000406	0.00045	CcSEcCtD
Tolcapone—Hypersensitivity—Leflunomide—systemic scleroderma	0.000406	0.00045	CcSEcCtD
Tolcapone—Pain—Lisinopril—systemic scleroderma	0.000405	0.000449	CcSEcCtD
Tolcapone—Constipation—Lisinopril—systemic scleroderma	0.000405	0.000449	CcSEcCtD
Tolcapone—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000405	0.000449	CcSEcCtD
Tolcapone—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000403	0.000447	CcSEcCtD
Tolcapone—Bradycardia—Prednisone—systemic scleroderma	0.000403	0.000447	CcSEcCtD
Tolcapone—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000401	0.000445	CcSEcCtD
Tolcapone—Diarrhoea—Azathioprine—systemic scleroderma	0.000399	0.000443	CcSEcCtD
Tolcapone—Haemoglobin—Prednisone—systemic scleroderma	0.000398	0.000441	CcSEcCtD
Tolcapone—Nausea—Captopril—systemic scleroderma	0.000397	0.00044	CcSEcCtD
Tolcapone—Haemorrhage—Prednisone—systemic scleroderma	0.000396	0.000439	CcSEcCtD
Tolcapone—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000395	0.000439	CcSEcCtD
Tolcapone—Asthenia—Leflunomide—systemic scleroderma	0.000395	0.000438	CcSEcCtD
Tolcapone—Hallucination—Prednisone—systemic scleroderma	0.000394	0.000437	CcSEcCtD
Tolcapone—Feeling abnormal—Lisinopril—systemic scleroderma	0.00039	0.000433	CcSEcCtD
Tolcapone—Pruritus—Leflunomide—systemic scleroderma	0.00039	0.000432	CcSEcCtD
Tolcapone—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000388	0.00043	CcSEcCtD
Tolcapone—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000387	0.000429	CcSEcCtD
Tolcapone—Dysuria—Methotrexate—systemic scleroderma	0.000386	0.000429	CcSEcCtD
Tolcapone—Dizziness—Azathioprine—systemic scleroderma	0.000386	0.000428	CcSEcCtD
Tolcapone—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000384	0.000426	CcSEcCtD
Tolcapone—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000381	0.000422	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000378	0.000419	CcSEcCtD
Tolcapone—Asthenia—Mycophenolic acid—systemic scleroderma	0.000377	0.000418	CcSEcCtD
Tolcapone—Diarrhoea—Leflunomide—systemic scleroderma	0.000377	0.000418	CcSEcCtD
Tolcapone—Urticaria—Lisinopril—systemic scleroderma	0.000376	0.000417	CcSEcCtD
Tolcapone—Body temperature increased—Lisinopril—systemic scleroderma	0.000374	0.000415	CcSEcCtD
Tolcapone—Abdominal pain—Lisinopril—systemic scleroderma	0.000374	0.000415	CcSEcCtD
Tolcapone—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000372	0.000413	CcSEcCtD
Tolcapone—Pruritus—Mycophenolic acid—systemic scleroderma	0.000372	0.000412	CcSEcCtD
Tolcapone—Vomiting—Azathioprine—systemic scleroderma	0.000371	0.000411	CcSEcCtD
Tolcapone—Pneumonia—Methotrexate—systemic scleroderma	0.000371	0.000411	CcSEcCtD
Tolcapone—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00037	0.00041	CcSEcCtD
Tolcapone—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000369	0.000409	CcSEcCtD
Tolcapone—Infestation NOS—Methotrexate—systemic scleroderma	0.000368	0.000409	CcSEcCtD
Tolcapone—Infestation—Methotrexate—systemic scleroderma	0.000368	0.000409	CcSEcCtD
Tolcapone—Rash—Azathioprine—systemic scleroderma	0.000368	0.000408	CcSEcCtD
Tolcapone—Dermatitis—Azathioprine—systemic scleroderma	0.000368	0.000408	CcSEcCtD
Tolcapone—Headache—Azathioprine—systemic scleroderma	0.000365	0.000405	CcSEcCtD
Tolcapone—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000365	0.000405	CcSEcCtD
Tolcapone—Dizziness—Leflunomide—systemic scleroderma	0.000364	0.000404	CcSEcCtD
Tolcapone—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000361	0.0004	CcSEcCtD
Tolcapone—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00036	0.000399	CcSEcCtD
Tolcapone—Stomatitis—Methotrexate—systemic scleroderma	0.000359	0.000398	CcSEcCtD
Tolcapone—Angiopathy—Prednisone—systemic scleroderma	0.000359	0.000398	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000358	0.000397	CcSEcCtD
Tolcapone—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000355	0.000393	CcSEcCtD
Tolcapone—Pain—Mycophenolate mofetil—systemic scleroderma	0.000355	0.000393	CcSEcCtD
Tolcapone—Arrhythmia—Prednisone—systemic scleroderma	0.000354	0.000392	CcSEcCtD
Tolcapone—Sweating—Methotrexate—systemic scleroderma	0.000353	0.000392	CcSEcCtD
Tolcapone—Haematuria—Methotrexate—systemic scleroderma	0.000351	0.00039	CcSEcCtD
Tolcapone—Vomiting—Leflunomide—systemic scleroderma	0.00035	0.000389	CcSEcCtD
Tolcapone—Alopecia—Prednisone—systemic scleroderma	0.00035	0.000388	CcSEcCtD
Tolcapone—Hypersensitivity—Lisinopril—systemic scleroderma	0.000349	0.000387	CcSEcCtD
Tolcapone—Dizziness—Mycophenolic acid—systemic scleroderma	0.000348	0.000385	CcSEcCtD
Tolcapone—Epistaxis—Methotrexate—systemic scleroderma	0.000348	0.000385	CcSEcCtD
Tolcapone—Rash—Leflunomide—systemic scleroderma	0.000347	0.000385	CcSEcCtD
Tolcapone—Dermatitis—Leflunomide—systemic scleroderma	0.000347	0.000385	CcSEcCtD
Tolcapone—Mental disorder—Prednisone—systemic scleroderma	0.000347	0.000385	CcSEcCtD
Tolcapone—Nausea—Azathioprine—systemic scleroderma	0.000347	0.000384	CcSEcCtD
Tolcapone—Headache—Leflunomide—systemic scleroderma	0.000345	0.000383	CcSEcCtD
Tolcapone—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000342	0.000379	CcSEcCtD
Tolcapone—Asthenia—Lisinopril—systemic scleroderma	0.00034	0.000377	CcSEcCtD
Tolcapone—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000339	0.000376	CcSEcCtD
Tolcapone—Pruritus—Lisinopril—systemic scleroderma	0.000335	0.000371	CcSEcCtD
Tolcapone—Vomiting—Mycophenolic acid—systemic scleroderma	0.000334	0.000371	CcSEcCtD
Tolcapone—Haemoglobin—Methotrexate—systemic scleroderma	0.000332	0.000369	CcSEcCtD
Tolcapone—Rash—Mycophenolic acid—systemic scleroderma	0.000331	0.000368	CcSEcCtD
Tolcapone—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000331	0.000367	CcSEcCtD
Tolcapone—Haemorrhage—Methotrexate—systemic scleroderma	0.000331	0.000367	CcSEcCtD
Tolcapone—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00033	0.000365	CcSEcCtD
Tolcapone—Headache—Mycophenolic acid—systemic scleroderma	0.000329	0.000365	CcSEcCtD
Tolcapone—Pharyngitis—Methotrexate—systemic scleroderma	0.000328	0.000364	CcSEcCtD
Tolcapone—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000328	0.000364	CcSEcCtD
Tolcapone—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000328	0.000364	CcSEcCtD
Tolcapone—Nausea—Leflunomide—systemic scleroderma	0.000327	0.000363	CcSEcCtD
Tolcapone—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000327	0.000362	CcSEcCtD
Tolcapone—Vision blurred—Prednisone—systemic scleroderma	0.000325	0.00036	CcSEcCtD
Tolcapone—Urethral disorder—Methotrexate—systemic scleroderma	0.000324	0.00036	CcSEcCtD
Tolcapone—Diarrhoea—Lisinopril—systemic scleroderma	0.000324	0.000359	CcSEcCtD
Tolcapone—Ill-defined disorder—Prednisone—systemic scleroderma	0.00032	0.000355	CcSEcCtD
Tolcapone—Anaemia—Prednisone—systemic scleroderma	0.000318	0.000353	CcSEcCtD
Tolcapone—Agitation—Prednisone—systemic scleroderma	0.000317	0.000351	CcSEcCtD
Tolcapone—Dizziness—Lisinopril—systemic scleroderma	0.000313	0.000347	CcSEcCtD
Tolcapone—Erythema multiforme—Methotrexate—systemic scleroderma	0.000313	0.000347	CcSEcCtD
Tolcapone—Nausea—Mycophenolic acid—systemic scleroderma	0.000312	0.000346	CcSEcCtD
Tolcapone—Malaise—Prednisone—systemic scleroderma	0.000311	0.000345	CcSEcCtD
Tolcapone—Vertigo—Prednisone—systemic scleroderma	0.00031	0.000343	CcSEcCtD
Tolcapone—Syncope—Prednisone—systemic scleroderma	0.000309	0.000343	CcSEcCtD
Tolcapone—Tinnitus—Methotrexate—systemic scleroderma	0.000308	0.000342	CcSEcCtD
Tolcapone—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000306	0.000339	CcSEcCtD
Tolcapone—Loss of consciousness—Prednisone—systemic scleroderma	0.000303	0.000336	CcSEcCtD
Tolcapone—Vomiting—Lisinopril—systemic scleroderma	0.000301	0.000334	CcSEcCtD
Tolcapone—Angiopathy—Methotrexate—systemic scleroderma	0.0003	0.000333	CcSEcCtD
Tolcapone—Rash—Lisinopril—systemic scleroderma	0.000298	0.000331	CcSEcCtD
Tolcapone—Dermatitis—Lisinopril—systemic scleroderma	0.000298	0.000331	CcSEcCtD
Tolcapone—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000298	0.000331	CcSEcCtD
Tolcapone—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000298	0.00033	CcSEcCtD
Tolcapone—Hypertension—Prednisone—systemic scleroderma	0.000297	0.00033	CcSEcCtD
Tolcapone—Chills—Methotrexate—systemic scleroderma	0.000297	0.000329	CcSEcCtD
Tolcapone—Headache—Lisinopril—systemic scleroderma	0.000297	0.000329	CcSEcCtD
Tolcapone—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000293	0.000325	CcSEcCtD
Tolcapone—Myalgia—Prednisone—systemic scleroderma	0.000293	0.000325	CcSEcCtD
Tolcapone—Arthralgia—Prednisone—systemic scleroderma	0.000293	0.000325	CcSEcCtD
Tolcapone—Anxiety—Prednisone—systemic scleroderma	0.000292	0.000324	CcSEcCtD
Tolcapone—Alopecia—Methotrexate—systemic scleroderma	0.000292	0.000324	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000291	0.000323	CcSEcCtD
Tolcapone—Discomfort—Prednisone—systemic scleroderma	0.00029	0.000321	CcSEcCtD
Tolcapone—Mental disorder—Methotrexate—systemic scleroderma	0.00029	0.000321	CcSEcCtD
Tolcapone—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000284	0.000315	CcSEcCtD
Tolcapone—Dysgeusia—Methotrexate—systemic scleroderma	0.000282	0.000313	CcSEcCtD
Tolcapone—Nausea—Lisinopril—systemic scleroderma	0.000281	0.000312	CcSEcCtD
Tolcapone—Oedema—Prednisone—systemic scleroderma	0.000281	0.000312	CcSEcCtD
Tolcapone—Infection—Prednisone—systemic scleroderma	0.000279	0.00031	CcSEcCtD
Tolcapone—Shock—Prednisone—systemic scleroderma	0.000277	0.000307	CcSEcCtD
Tolcapone—Nervous system disorder—Prednisone—systemic scleroderma	0.000276	0.000306	CcSEcCtD
Tolcapone—Tachycardia—Prednisone—systemic scleroderma	0.000274	0.000304	CcSEcCtD
Tolcapone—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000274	0.000304	CcSEcCtD
Tolcapone—Skin disorder—Prednisone—systemic scleroderma	0.000273	0.000303	CcSEcCtD
Tolcapone—Hyperhidrosis—Prednisone—systemic scleroderma	0.000272	0.000301	CcSEcCtD
Tolcapone—Vision blurred—Methotrexate—systemic scleroderma	0.000271	0.000301	CcSEcCtD
Tolcapone—Anorexia—Prednisone—systemic scleroderma	0.000268	0.000297	CcSEcCtD
Tolcapone—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000267	0.000296	CcSEcCtD
Tolcapone—Anaemia—Methotrexate—systemic scleroderma	0.000266	0.000295	CcSEcCtD
Tolcapone—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000264	0.000293	CcSEcCtD
Tolcapone—Rash—Mycophenolate mofetil—systemic scleroderma	0.000262	0.00029	CcSEcCtD
Tolcapone—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000261	0.00029	CcSEcCtD
Tolcapone—Headache—Mycophenolate mofetil—systemic scleroderma	0.00026	0.000288	CcSEcCtD
Tolcapone—Malaise—Methotrexate—systemic scleroderma	0.00026	0.000288	CcSEcCtD
Tolcapone—Vertigo—Methotrexate—systemic scleroderma	0.000259	0.000287	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000256	0.000284	CcSEcCtD
Tolcapone—Paraesthesia—Prednisone—systemic scleroderma	0.000252	0.00028	CcSEcCtD
Tolcapone—Cough—Methotrexate—systemic scleroderma	0.000251	0.000279	CcSEcCtD
Tolcapone—Dyspepsia—Prednisone—systemic scleroderma	0.000247	0.000275	CcSEcCtD
Tolcapone—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000246	0.000273	CcSEcCtD
Tolcapone—Arthralgia—Methotrexate—systemic scleroderma	0.000245	0.000272	CcSEcCtD
Tolcapone—Chest pain—Methotrexate—systemic scleroderma	0.000245	0.000272	CcSEcCtD
Tolcapone—Myalgia—Methotrexate—systemic scleroderma	0.000245	0.000272	CcSEcCtD
Tolcapone—Decreased appetite—Prednisone—systemic scleroderma	0.000244	0.000271	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000243	0.00027	CcSEcCtD
Tolcapone—Fatigue—Prednisone—systemic scleroderma	0.000242	0.000269	CcSEcCtD
Tolcapone—Discomfort—Methotrexate—systemic scleroderma	0.000242	0.000269	CcSEcCtD
Tolcapone—Constipation—Prednisone—systemic scleroderma	0.00024	0.000267	CcSEcCtD
Tolcapone—Confusional state—Methotrexate—systemic scleroderma	0.000237	0.000263	CcSEcCtD
Tolcapone—Infection—Methotrexate—systemic scleroderma	0.000233	0.000259	CcSEcCtD
Tolcapone—Feeling abnormal—Prednisone—systemic scleroderma	0.000232	0.000257	CcSEcCtD
Tolcapone—Nervous system disorder—Methotrexate—systemic scleroderma	0.00023	0.000256	CcSEcCtD
Tolcapone—Thrombocytopenia—Methotrexate—systemic scleroderma	0.00023	0.000255	CcSEcCtD
Tolcapone—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00023	0.000255	CcSEcCtD
Tolcapone—Skin disorder—Methotrexate—systemic scleroderma	0.000228	0.000253	CcSEcCtD
Tolcapone—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000227	0.000252	CcSEcCtD
Tolcapone—Anorexia—Methotrexate—systemic scleroderma	0.000224	0.000248	CcSEcCtD
Tolcapone—Urticaria—Prednisone—systemic scleroderma	0.000223	0.000248	CcSEcCtD
Tolcapone—Abdominal pain—Prednisone—systemic scleroderma	0.000222	0.000247	CcSEcCtD
Tolcapone—Body temperature increased—Prednisone—systemic scleroderma	0.000222	0.000247	CcSEcCtD
Tolcapone—Hypotension—Methotrexate—systemic scleroderma	0.00022	0.000244	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000214	0.000237	CcSEcCtD
Tolcapone—Paraesthesia—Methotrexate—systemic scleroderma	0.000211	0.000234	CcSEcCtD
Tolcapone—Dyspnoea—Methotrexate—systemic scleroderma	0.000209	0.000232	CcSEcCtD
Tolcapone—Somnolence—Methotrexate—systemic scleroderma	0.000209	0.000232	CcSEcCtD
Tolcapone—Hypersensitivity—Prednisone—systemic scleroderma	0.000207	0.00023	CcSEcCtD
Tolcapone—Dyspepsia—Methotrexate—systemic scleroderma	0.000207	0.000229	CcSEcCtD
Tolcapone—Decreased appetite—Methotrexate—systemic scleroderma	0.000204	0.000227	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000203	0.000225	CcSEcCtD
Tolcapone—Fatigue—Methotrexate—systemic scleroderma	0.000203	0.000225	CcSEcCtD
Tolcapone—Asthenia—Prednisone—systemic scleroderma	0.000202	0.000224	CcSEcCtD
Tolcapone—Pain—Methotrexate—systemic scleroderma	0.000201	0.000223	CcSEcCtD
Tolcapone—Pruritus—Prednisone—systemic scleroderma	0.000199	0.000221	CcSEcCtD
Tolcapone—Feeling abnormal—Methotrexate—systemic scleroderma	0.000194	0.000215	CcSEcCtD
Tolcapone—Diarrhoea—Prednisone—systemic scleroderma	0.000192	0.000213	CcSEcCtD
Tolcapone—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000192	0.000213	CcSEcCtD
Tolcapone—Urticaria—Methotrexate—systemic scleroderma	0.000187	0.000207	CcSEcCtD
Tolcapone—Dizziness—Prednisone—systemic scleroderma	0.000186	0.000206	CcSEcCtD
Tolcapone—Abdominal pain—Methotrexate—systemic scleroderma	0.000186	0.000206	CcSEcCtD
Tolcapone—Body temperature increased—Methotrexate—systemic scleroderma	0.000186	0.000206	CcSEcCtD
Tolcapone—Vomiting—Prednisone—systemic scleroderma	0.000179	0.000198	CcSEcCtD
Tolcapone—Rash—Prednisone—systemic scleroderma	0.000177	0.000197	CcSEcCtD
Tolcapone—Dermatitis—Prednisone—systemic scleroderma	0.000177	0.000196	CcSEcCtD
Tolcapone—Headache—Prednisone—systemic scleroderma	0.000176	0.000195	CcSEcCtD
Tolcapone—Hypersensitivity—Methotrexate—systemic scleroderma	0.000173	0.000192	CcSEcCtD
Tolcapone—Asthenia—Methotrexate—systemic scleroderma	0.000169	0.000187	CcSEcCtD
Tolcapone—Nausea—Prednisone—systemic scleroderma	0.000167	0.000185	CcSEcCtD
Tolcapone—Pruritus—Methotrexate—systemic scleroderma	0.000166	0.000184	CcSEcCtD
Tolcapone—Diarrhoea—Methotrexate—systemic scleroderma	0.000161	0.000178	CcSEcCtD
Tolcapone—Dizziness—Methotrexate—systemic scleroderma	0.000155	0.000172	CcSEcCtD
Tolcapone—Vomiting—Methotrexate—systemic scleroderma	0.000149	0.000166	CcSEcCtD
Tolcapone—Rash—Methotrexate—systemic scleroderma	0.000148	0.000164	CcSEcCtD
Tolcapone—Dermatitis—Methotrexate—systemic scleroderma	0.000148	0.000164	CcSEcCtD
Tolcapone—Headache—Methotrexate—systemic scleroderma	0.000147	0.000163	CcSEcCtD
Tolcapone—Nausea—Methotrexate—systemic scleroderma	0.00014	0.000155	CcSEcCtD
